Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia

Cell Reports

Volumn 16, Issue 8, 2016, Pages 2116-2128

  Managò, Francesca ^a   Mereu, Maddalena ^b   Mastwal, Surjeet ^c   Mastrogiacomo, Rosa ^a   Scheggia, Diego ^a   Emanuele, Marco ^a   De Luca, Maria A ^d   Weinberger, Daniel R ^e,f   Wang, Kuan Hong ^c   Papaleo, Francesco ^a  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; AMPHETAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ETICLOPRIDE; ACTIVITY REGULATED CYTOSKELETAL-ASSOCIATED PROTEIN; CYTOSKELETON PROTEIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; NERVE PROTEIN; SALICYLAMIDE DERIVATIVE;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINE RELEASE; FEMALE; GENE DISRUPTION; HUMAN; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; NUCLEUS ACCUMBENS SHELL; PHENOTYPE; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; PSYCHOMOTOR DISORDER; SCHIZOPHRENIA; SENSORY GATING; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; STARTLE REFLEX; SUPERSENSITIVITY; VENTRAL STRIATUM; ANIMAL; CORPUS STRIATUM; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; SYNAPTIC TRANSMISSION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; AMPHETAMINE; ANIMALS; COGNITIVE DYSFUNCTION; CORPUS STRIATUM; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FEMALE; GENE EXPRESSION; MALE; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PHENOTYPE; PREFRONTAL CORTEX; PSYCHOMOTOR DISORDERS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; SCHIZOPHRENIA; SENSORY GATING; SYNAPTIC TRANSMISSION;

EID: 84981738094     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.07.044     Document Type: Article

References (76)

1. Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L.S., Weiss, R., Cooper, T.B., Mann, J.J., Van Heertum, R.L., et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. USA 97 (2000), 8104–8109.
2. Anzalone, A., Lizardi-Ortiz, J.E., Ramos, M., De Mei, C., Hopf, F.W., Iaccarino, C., Halbout, B., Jacobsen, J., Kinoshita, C., Welter, M., et al. Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J. Neurosci. 32 (2012), 9023–9034.
3. Baker, D.A., Khroyan, T.V., O'Dell, L.E., Fuchs, R.A., Neisewander, J.L., Differential effects of intra-accumbens sulpiride on cocaine-induced locomotion and conditioned place preference. J. Pharmacol. Exp. Ther. 279 (1996), 392–401.
4. Barker, G.R., Warburton, E.C., When is the hippocampus involved in recognition memory?. J. Neurosci. 31 (2011), 10721–10731.
5. Barker, G.R., Bird, F., Alexander, V., Warburton, E.C., Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. J. Neurosci. 27 (2007), 2948–2957.
6. Beaulieu, J.M., Gainetdinov, R.R., Caron, M.G., The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol. Sci. 28 (2007), 166–172.
7. Beckstead, R.M., Domesick, V.B., Nauta, W.J., Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175 (1979), 191–217.
8. Cao, V.Y., Ye, Y., Mastwal, S., Ren, M., Coon, M., Liu, Q., Costa, R.M., Wang, K.H., Motor Learning Consolidates Arc-Expressing Neuronal Ensembles in Secondary Motor Cortex. Neuron 86 (2015), 1385–1392.
9. Carr, D.B., Sesack, S.R., Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 20 (2000), 3864–3873.
10. Chausmer, A., Ettenberg, A., Intraaccumbens raclopride attenuates amphetamine-induced locomotion, but fails to prevent the response-reinstating properties of food reinforcement. Pharmacol. Biochem. Behav. 62 (1999), 299–305.
11. Chowdhury, S., Shepherd, J.D., Okuno, H., Lyford, G., Petralia, R.S., Plath, N., Kuhl, D., Huganir, R.L., Worley, P.F., Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron 52 (2006), 445–459.
12. Clarke, H.F., Cardinal, R.N., Rygula, R., Hong, Y.T., Fryer, T.D., Sawiak, S.J., Ferrari, V., Cockcroft, G., Aigbirhio, F.I., Robbins, T.W., Roberts, A.C., Orbitofrontal dopamine depletion upregulates caudate dopamine and alters behavior via changes in reinforcement sensitivity. J. Neurosci. 34 (2014), 7663–7676.
13. De Luca, M.A., Cauli, O., Morelli, M., Simola, N., Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?. J. Neurochem. 131 (2014), 284–289.
14. Dreher, J.C., Banquet, J.P., Allilaire, J.F., Paillère-Martinot, M.L., Dubois, B., Burnod, Y., Temporal order and spatial memory in schizophrenia: a parametric study. Schizophr. Res. 51 (2001), 137–147.
15. Dreher, J.C., Koch, P., Kohn, P., Apud, J., Weinberger, D.R., Berman, K.F., Common and differential pathophysiological features accompany comparable cognitive impairments in medication-free patients with schizophrenia and in healthy aging subjects. Biol. Psychiatry 71 (2012), 890–897.
16. Emamian, E.S., Hall, D., Birnbaum, M.J., Karayiorgou, M., Gogos, J.A., Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 36 (2004), 131–137.
17. Ferenczi, E.A., Zalocusky, K.A., Liston, C., Grosenick, L., Warden, M.R., Amatya, D., Katovich, K., Mehta, H., Patenaude, B., Ramakrishnan, C., et al. Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior. Science, 351, 2016, aac9698.
18. Folley, B.S., Astur, R., Jagannathan, K., Calhoun, V.D., Pearlson, G.D., Anomalous neural circuit function in schizophrenia during a virtual Morris water task. Neuroimage 49 (2010), 3373–3384.
19. Franklin, K.B.J., Paxinos, G., The Mouse Brain in Stereotaxic Coordinates. 1997, Academic Press.
20. Fromer, M., Pocklington, A.J., Kavanagh, D.H., Williams, H.J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D.M., et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506 (2014), 179–184.
21. Guillozet-Bongaarts, A.L., Hyde, T.M., Dalley, R.A., Hawrylycz, M.J., Henry, A., Hof, P.R., Hohmann, J., Jones, A.R., Kuan, C.L., Royall, J., et al. Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol. Psychiatry 19 (2014), 478–485.
22. Hanks, A.N., Dlugolenski, K., Hughes, Z.A., Seymour, P.A., Majchrzak, M.J., Pharmacological disruption of mouse social approach behavior: relevance to negative symptoms of schizophrenia. Behav. Brain Res. 252 (2013), 405–414.
23. Heidbreder, C., Feldon, J., Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens. Synapse 29 (1998), 310–322.
24. Howes, O.D., Kapur, S., The dopamine hypothesis of schizophrenia: version III–the final common pathway. Schizophr. Bull. 35 (2009), 549–562.
25. Hu, J., Sathanoori, M., Kochmar, S., Azage, M., Mann, S., Madan-Khetarpal, S., Goldstein, A., Surti, U., A novel maternally inherited 8q24.3 and a rare paternally inherited 14q23.3 CNVs in a family with neurodevelopmental disorders. Am. J. Med. Genet. A. 167A (2015), 1921–1926.
26. Huang, H., Michetti, C., Busnelli, M., Managò, F., Sannino, S., Scheggia, D., Giancardo, L., Sona, D., Murino, V., Chini, B., et al. Chronic and acute intranasal oxytocin produce divergent social effects in mice. Neuropsychopharmacology 39 (2014), 1102–1114.
27. Huentelman, M.J., Muppana, L., Corneveaux, J.J., Dinu, V., Pruzin, J.J., Reiman, R., Borish, C.N., De Both, M., Ahmed, A., Todorov, A., et al. Association of SNPs in EGR3 and ARC with schizophrenia supports a biological pathway for schizophrenia risk. PLoS ONE, 10, 2015, e0135076.
28. Ikemoto, S., Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists. Neuroscience 113 (2002), 939–955.
29. Jakkamsetti, V., Tsai, N.P., Gross, C., Molinaro, G., Collins, K.A., Nicoletti, F., Wang, K.H., Osten, P., Bassell, G.J., Gibson, J.R., Huber, K.M., Experience-induced Arc/Arg3.1 primes CA1 pyramidal neurons for metabotropic glutamate receptor-dependent long-term synaptic depression. Neuron 80 (2013), 72–79.
30. Kalsbeek, A., Voorn, P., Buijs, R.M., Pool, C.W., Uylings, H.B., Development of the dopaminergic innervation in the prefrontal cortex of the rat. J. Comp. Neurol. 269 (1988), 58–72.
31. Kellendonk, C., Simpson, E.H., Polan, H.J., Malleret, G., Vronskaya, S., Winiger, V., Moore, H., Kandel, E.R., Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49 (2006), 603–615.
32. Koch, K., Rus, O.G., Reeß, T.J., Schachtzabel, C., Wagner, G., Schultz, C.C., Sorg, C., Schlösser, R.G., Functional connectivity and grey matter volume of the striatum in schizophrenia. Br. J. Psychiatry 205 (2014), 204–213.
33. Kozorovitskiy, Y., Saunders, A., Johnson, C.A., Lowell, B.B., Sabatini, B.L., Recurrent network activity drives striatal synaptogenesis. Nature 485 (2012), 646–650.
34. Lacroix, L., Broersen, L.M., Feldon, J., Weiner, I., Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behav. Brain Res. 107 (2000), 111–121.
35. Laruelle, M., Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q. J. Nucl. Med. 42 (1998), 211–221.
36. Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., Innis, R., Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol. Psychiatry 46 (1999), 56–72.
37. Lavin, A., Nogueira, L., Lapish, C.C., Wightman, R.M., Phillips, P.E., Seamans, J.K., Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. J. Neurosci. 25 (2005), 5013–5023.
38. Lewis, B.L., O'Donnell, P., Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential ‘up’ states in pyramidal neurons via D(1) dopamine receptors. Cereb. Cortex 10 (2000), 1168–1175.
39. Mastwal, S., Ye, Y., Ren, M., Jimenez, D.V., Martinowich, K., Gerfen, C.R., Wang, K.H., Phasic dopamine neuron activity elicits unique mesofrontal plasticity in adolescence. J. Neurosci. 34 (2014), 9484–9496.
40. McCurry, C.L., Shepherd, J.D., Tropea, D., Wang, K.H., Bear, M.F., Sur, M., Loss of Arc renders the visual cortex impervious to the effects of sensory experience or deprivation. Nat. Neurosci. 13 (2010), 450–457.
41. Millan, M.J., Fone, K., Steckler, T., Horan, W.P., Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. Eur. Neuropsychopharmacol. 24 (2014), 645–692.
42. Miyashita, T., Kubik, S., Lewandowski, G., Guzowski, J.F., Networks of neurons, networks of genes: an integrated view of memory consolidation. Neurobiol. Learn. Mem. 89 (2008), 269–284.
43. Papaleo, F., Crawley, J.N., Song, J., Lipska, B.K., Pickel, J., Weinberger, D.R., Chen, J., Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J. Neurosci. 28 (2008), 8709–8723.
44. Papaleo, F., Silverman, J.L., Aney, J., Tian, Q., Barkan, C.L., Chadman, K.K., Crawley, J.N., Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learn. Mem. 18 (2011), 534–544.
45. Papaleo, F., Yang, F., Garcia, S., Chen, J., Lu, B., Crawley, J.N., Weinberger, D.R., Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol. Psychiatry 17 (2012), 85–98.
46. Papaleo, F., Burdick, M.C., Callicott, J.H., Weinberger, D.R., Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans. Mol. Psychiatry 19 (2014), 311–316.
47. Park, S., Park, J.M., Kim, S., Kim, J.A., Shepherd, J.D., Smith-Hicks, C.L., Chowdhury, S., Kaufmann, W., Kuhl, D., Ryazanov, A.G., et al. Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 59 (2008), 70–83.
48. Plath, N., Ohana, O., Dammermann, B., Errington, M.L., Schmitz, D., Gross, C., Mao, X., Engelsberg, A., Mahlke, C., Welzl, H., et al. Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 52 (2006), 437–444.
49. Purcell, S.M., Moran, J.L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O'Dushlaine, C., Chambert, K., Bergen, S.E., Kähler, A., et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506 (2014), 185–190.
50. Pycock, C.J., Kerwin, R.W., Carter, C.J., Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286 (1980), 74–76.
51. Rasetti, R., Mattay, V.S., White, M.G., Sambataro, F., Podell, J.E., Zoltick, B., Chen, Q., Berman, K.F., Callicott, J.H., Weinberger, D.R., Altered hippocampal-parahippocampal function during stimulus encoding: a potential indicator of genetic liability for schizophrenia. JAMA Psychiatry 71 (2014), 236–247.
52. Ren, M., Cao, V., Ye, Y., Manji, H.K., Wang, K.H., Arc regulates experience-dependent persistent firing patterns in frontal cortex. J. Neurosci. 34 (2014), 6583–6595.
53. Rial Verde, E.M., Lee-Osbourne, J., Worley, P.F., Malinow, R., Cline, H.T., Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission. Neuron 52 (2006), 461–474.
54. Rizzo, L., Danion, J.M., van der Linden, M., Grangé, D., Patients with schizophrenia remember that an event has occurred, but not when. Br. J. Psychiatry 168 (1996), 427–431.
55. Robbins, T.W., Arnsten, A.F., The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu. Rev. Neurosci. 32 (2009), 267–287.
56. Saunders, R.C., Kolachana, B.S., Bachevalier, J., Weinberger, D.R., Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature 393 (1998), 169–171.
57. Schwartz, B.L., Deutsch, L.H., Cohen, C., Warden, D., Deutsch, S.I., Memory for temporal order in schizophrenia. Biol. Psychiatry 29 (1991), 329–339.
58. Scornaiencki, R., Cantrup, R., Rushlow, W.J., Rajakumar, N., Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness. Int. J. Neuropsychopharmacol. 12 (2009), 1195–1208.
59. Shepherd, J.D., Bear, M.F., New views of Arc, a master regulator of synaptic plasticity. Nat. Neurosci. 14 (2011), 279–284.
60. Shepherd, J.D., Rumbaugh, G., Wu, J., Chowdhury, S., Plath, N., Kuhl, D., Huganir, R.L., Worley, P.F., Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron 52 (2006), 475–484.
61. Simpson, E.H., Kellendonk, C., Kandel, E., A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron 65 (2010), 585–596.
62. Slifstein, M., van de Giessen, E., Van Snellenberg, J., Thompson, J.L., Narendran, R., Gil, R., Hackett, E., Girgis, R., Ojeil, N., Moore, H., et al. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry 72 (2015), 316–324.
63. Sullivan, P.F., Kendler, K.S., Neale, M.C., Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60 (2003), 1187–1192.
64. Swerdlow, N.R., Light, G.A., Cadenhead, K.S., Sprock, J., Hsieh, M.H., Braff, D.L., Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch. Gen. Psychiatry 63 (2006), 1325–1335.
65. Swerdlow, N.R., Weber, M., Qu, Y., Light, G.A., Braff, D.L., Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl.) 199 (2008), 331–388.
66. Tzschentke, T.M., Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog. Neurobiol. 63 (2001), 241–320.
67. van den Boss, R., Cools, A.R., Ogren, S.O., Differential effects of the selective D2-antagonist raclopride in the nucleus accumbens of the rat on spontaneous and d-amphetamine-induced activity. Psychopharmacology (Berl.) 95 (1988), 447–451.
68. van den Buuse, M., Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr. Bull. 36 (2010), 246–270.
69. Vazdarjanova, A., Ramirez-Amaya, V., Insel, N., Plummer, T.K., Rosi, S., Chowdhury, S., Mikhael, D., Worley, P.F., Guzowski, J.F., Barnes, C.A., Spatial exploration induces ARC, a plasticity-related immediate-early gene, only in calcium/calmodulin-dependent protein kinase II-positive principal excitatory and inhibitory neurons of the rat forebrain. J. Comp. Neurol. 498 (2006), 317–329.
70. Vijayraghavan, S., Wang, M., Birnbaum, S.G., Williams, G.V., Arnsten, A.F., Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat. Neurosci. 10 (2007), 376–384.
71. Wang, K.H., Majewska, A., Schummers, J., Farley, B., Hu, C., Sur, M., Tonegawa, S., In vivo two-photon imaging reveals a role of arc in enhancing orientation specificity in visual cortex. Cell 126 (2006), 389–402.
72. Waung, M.W., Pfeiffer, B.E., Nosyreva, E.D., Ronesi, J.A., Huber, K.M., Rapid translation of Arc/Arg3.1 selectively mediates mGluR-dependent LTD through persistent increases in AMPAR endocytosis rate. Neuron 59 (2008), 84–97.
73. Weinstein, J.J., Chohan, M.O., Slifstein, M., Kegeles, L.S., Moore, H., Abi-Dargham, A., Pathway-specific dopamine abnormalities in schizophrenia. Biol. Psychiatry, 2016, 10.1016/j.biopsych.2016.03.2104 Published online March 13, 2016.
74. Winterer, G., Weinberger, D.R., Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 27 (2004), 683–690.
75. Zhang, W., Wu, J., Ward, M.D., Yang, S., Chuang, Y.A., Xiao, M., Li, R., Leahy, D.J., Worley, P.F., Structural basis of arc binding to synaptic proteins: implications for cognitive disease. Neuron 86 (2015), 490–500.
76. Zhao, Z., Ksiezak-Reding, H., Riggio, S., Haroutunian, V., Pasinetti, G.M., Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophr. Res. 84 (2006), 1–14.